0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Icatibant Acetate Injection Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-30Y18055
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Icatibant Acetate Injection Market Research Report 2024
BUY CHAPTERS

Global Icatibant Acetate Injection Market Research Report 2024

Code: QYRE-Auto-30Y18055
Report
October 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Icatibant Acetate Injection Market

Icatibant acetate injection is a synthetic bradykinin B2 receptor antagonist used to treat acute attacks of hereditary angioedema (HAE). Administered subcutaneously, icatibant provides rapid relief from symptoms like facial, throat, or abdominal swelling, and is a key treatment option for managing acute HAE attacks.
The global Icatibant Acetate Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Icatibant Acetate Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Icatibant Acetate Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Icatibant Acetate Injection include Takeda Pharmaceuticals, Eugia Pharma Specialities, Glenmark Pharmaceuticals, Sandoz, Cipla, Fresenius Kabi, Jiangsu Hengrui Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Icatibant Acetate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Icatibant Acetate Injection.
The Icatibant Acetate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Icatibant Acetate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Icatibant Acetate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Icatibant Acetate Injection Market Report

Report Metric Details
Report Name Icatibant Acetate Injection Market
Segment by Type
Segment by Application
  • Hospital and Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda Pharmaceuticals, Eugia Pharma Specialities, Glenmark Pharmaceuticals, Sandoz, Cipla, Fresenius Kabi, Jiangsu Hengrui Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Icatibant Acetate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Icatibant Acetate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Icatibant Acetate Injection Market report?

Ans: The main players in the Icatibant Acetate Injection Market are Takeda Pharmaceuticals, Eugia Pharma Specialities, Glenmark Pharmaceuticals, Sandoz, Cipla, Fresenius Kabi, Jiangsu Hengrui Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy

What are the Application segmentation covered in the Icatibant Acetate Injection Market report?

Ans: The Applications covered in the Icatibant Acetate Injection Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Icatibant Acetate Injection Market report?

Ans: The Types covered in the Icatibant Acetate Injection Market report are Original Drug, Generic Drug

Recommended Reports

Injection Therapies

Acetate API Markets

Allergy & Edema Treatments

1 Icatibant Acetate Injection Market Overview
1.1 Product Definition
1.2 Icatibant Acetate Injection by Type
1.2.1 Global Icatibant Acetate Injection Market Value Comparison by Type (2024-2030)
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Icatibant Acetate Injection by Application
1.3.1 Global Icatibant Acetate Injection Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Icatibant Acetate Injection Market Size Estimates and Forecasts
1.4.1 Global Icatibant Acetate Injection Revenue 2019-2030
1.4.2 Global Icatibant Acetate Injection Sales 2019-2030
1.4.3 Global Icatibant Acetate Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Icatibant Acetate Injection Market Competition by Manufacturers
2.1 Global Icatibant Acetate Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Icatibant Acetate Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Icatibant Acetate Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Icatibant Acetate Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Icatibant Acetate Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Icatibant Acetate Injection, Product Type & Application
2.7 Global Key Manufacturers of Icatibant Acetate Injection, Date of Enter into This Industry
2.8 Global Icatibant Acetate Injection Market Competitive Situation and Trends
2.8.1 Global Icatibant Acetate Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Icatibant Acetate Injection Players Market Share by Revenue
2.8.3 Global Icatibant Acetate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Icatibant Acetate Injection Market Scenario by Region
3.1 Global Icatibant Acetate Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Icatibant Acetate Injection Sales by Region: 2019-2030
3.2.1 Global Icatibant Acetate Injection Sales by Region: 2019-2024
3.2.2 Global Icatibant Acetate Injection Sales by Region: 2025-2030
3.3 Global Icatibant Acetate Injection Revenue by Region: 2019-2030
3.3.1 Global Icatibant Acetate Injection Revenue by Region: 2019-2024
3.3.2 Global Icatibant Acetate Injection Revenue by Region: 2025-2030
3.4 North America Icatibant Acetate Injection Market Facts & Figures by Country
3.4.1 North America Icatibant Acetate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Icatibant Acetate Injection Sales by Country (2019-2030)
3.4.3 North America Icatibant Acetate Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Icatibant Acetate Injection Market Facts & Figures by Country
3.5.1 Europe Icatibant Acetate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Icatibant Acetate Injection Sales by Country (2019-2030)
3.5.3 Europe Icatibant Acetate Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Icatibant Acetate Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Icatibant Acetate Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Icatibant Acetate Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Icatibant Acetate Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Icatibant Acetate Injection Market Facts & Figures by Country
3.7.1 Latin America Icatibant Acetate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Icatibant Acetate Injection Sales by Country (2019-2030)
3.7.3 Latin America Icatibant Acetate Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Icatibant Acetate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Icatibant Acetate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Icatibant Acetate Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Icatibant Acetate Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Icatibant Acetate Injection Sales by Type (2019-2030)
4.1.1 Global Icatibant Acetate Injection Sales by Type (2019-2024)
4.1.2 Global Icatibant Acetate Injection Sales by Type (2025-2030)
4.1.3 Global Icatibant Acetate Injection Sales Market Share by Type (2019-2030)
4.2 Global Icatibant Acetate Injection Revenue by Type (2019-2030)
4.2.1 Global Icatibant Acetate Injection Revenue by Type (2019-2024)
4.2.2 Global Icatibant Acetate Injection Revenue by Type (2025-2030)
4.2.3 Global Icatibant Acetate Injection Revenue Market Share by Type (2019-2030)
4.3 Global Icatibant Acetate Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Icatibant Acetate Injection Sales by Application (2019-2030)
5.1.1 Global Icatibant Acetate Injection Sales by Application (2019-2024)
5.1.2 Global Icatibant Acetate Injection Sales by Application (2025-2030)
5.1.3 Global Icatibant Acetate Injection Sales Market Share by Application (2019-2030)
5.2 Global Icatibant Acetate Injection Revenue by Application (2019-2030)
5.2.1 Global Icatibant Acetate Injection Revenue by Application (2019-2024)
5.2.2 Global Icatibant Acetate Injection Revenue by Application (2025-2030)
5.2.3 Global Icatibant Acetate Injection Revenue Market Share by Application (2019-2030)
5.3 Global Icatibant Acetate Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda Pharmaceuticals
6.1.1 Takeda Pharmaceuticals Company Information
6.1.2 Takeda Pharmaceuticals Description and Business Overview
6.1.3 Takeda Pharmaceuticals Icatibant Acetate Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Pharmaceuticals Icatibant Acetate Injection Product Portfolio
6.1.5 Takeda Pharmaceuticals Recent Developments/Updates
6.2 Eugia Pharma Specialities
6.2.1 Eugia Pharma Specialities Company Information
6.2.2 Eugia Pharma Specialities Description and Business Overview
6.2.3 Eugia Pharma Specialities Icatibant Acetate Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eugia Pharma Specialities Icatibant Acetate Injection Product Portfolio
6.2.5 Eugia Pharma Specialities Recent Developments/Updates
6.3 Glenmark Pharmaceuticals
6.3.1 Glenmark Pharmaceuticals Company Information
6.3.2 Glenmark Pharmaceuticals Description and Business Overview
6.3.3 Glenmark Pharmaceuticals Icatibant Acetate Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glenmark Pharmaceuticals Icatibant Acetate Injection Product Portfolio
6.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Company Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Icatibant Acetate Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz Icatibant Acetate Injection Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Icatibant Acetate Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cipla Icatibant Acetate Injection Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Fresenius Kabi
6.6.1 Fresenius Kabi Company Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Icatibant Acetate Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Fresenius Kabi Icatibant Acetate Injection Product Portfolio
6.6.5 Fresenius Kabi Recent Developments/Updates
6.7 Jiangsu Hengrui Pharmaceuticals
6.7.1 Jiangsu Hengrui Pharmaceuticals Company Information
6.7.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview
6.7.3 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product Portfolio
6.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.8 Chengdu Shengnuo Biology Pharmacy
6.8.1 Chengdu Shengnuo Biology Pharmacy Company Information
6.8.2 Chengdu Shengnuo Biology Pharmacy Description and Business Overview
6.8.3 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product Portfolio
6.8.5 Chengdu Shengnuo Biology Pharmacy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Icatibant Acetate Injection Industry Chain Analysis
7.2 Icatibant Acetate Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Icatibant Acetate Injection Production Mode & Process
7.4 Icatibant Acetate Injection Sales and Marketing
7.4.1 Icatibant Acetate Injection Sales Channels
7.4.2 Icatibant Acetate Injection Distributors
7.5 Icatibant Acetate Injection Customers
8 Icatibant Acetate Injection Market Dynamics
8.1 Icatibant Acetate Injection Industry Trends
8.2 Icatibant Acetate Injection Market Drivers
8.3 Icatibant Acetate Injection Market Challenges
8.4 Icatibant Acetate Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Icatibant Acetate Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Icatibant Acetate Injection Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Icatibant Acetate Injection Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Icatibant Acetate Injection Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Icatibant Acetate Injection Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Icatibant Acetate Injection Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Icatibant Acetate Injection Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Icatibant Acetate Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Icatibant Acetate Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Icatibant Acetate Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Icatibant Acetate Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Icatibant Acetate Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Icatibant Acetate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Icatibant Acetate Injection as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Icatibant Acetate Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Icatibant Acetate Injection Sales by Region (2019-2024) & (K Units)
 Table 18. Global Icatibant Acetate Injection Sales Market Share by Region (2019-2024)
 Table 19. Global Icatibant Acetate Injection Sales by Region (2025-2030) & (K Units)
 Table 20. Global Icatibant Acetate Injection Sales Market Share by Region (2025-2030)
 Table 21. Global Icatibant Acetate Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Icatibant Acetate Injection Revenue Market Share by Region (2019-2024)
 Table 23. Global Icatibant Acetate Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Icatibant Acetate Injection Revenue Market Share by Region (2025-2030)
 Table 25. North America Icatibant Acetate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Icatibant Acetate Injection Sales by Country (2019-2024) & (K Units)
 Table 27. North America Icatibant Acetate Injection Sales by Country (2025-2030) & (K Units)
 Table 28. North America Icatibant Acetate Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Icatibant Acetate Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Icatibant Acetate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Icatibant Acetate Injection Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Icatibant Acetate Injection Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Icatibant Acetate Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Icatibant Acetate Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Icatibant Acetate Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Icatibant Acetate Injection Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Icatibant Acetate Injection Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Icatibant Acetate Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Icatibant Acetate Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Icatibant Acetate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Icatibant Acetate Injection Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Icatibant Acetate Injection Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Icatibant Acetate Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Icatibant Acetate Injection Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Icatibant Acetate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Icatibant Acetate Injection Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Icatibant Acetate Injection Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Icatibant Acetate Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Icatibant Acetate Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Icatibant Acetate Injection Sales (K Units) by Type (2019-2024)
 Table 51. Global Icatibant Acetate Injection Sales (K Units) by Type (2025-2030)
 Table 52. Global Icatibant Acetate Injection Sales Market Share by Type (2019-2024)
 Table 53. Global Icatibant Acetate Injection Sales Market Share by Type (2025-2030)
 Table 54. Global Icatibant Acetate Injection Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Icatibant Acetate Injection Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Icatibant Acetate Injection Revenue Market Share by Type (2019-2024)
 Table 57. Global Icatibant Acetate Injection Revenue Market Share by Type (2025-2030)
 Table 58. Global Icatibant Acetate Injection Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Icatibant Acetate Injection Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Icatibant Acetate Injection Sales (K Units) by Application (2019-2024)
 Table 61. Global Icatibant Acetate Injection Sales (K Units) by Application (2025-2030)
 Table 62. Global Icatibant Acetate Injection Sales Market Share by Application (2019-2024)
 Table 63. Global Icatibant Acetate Injection Sales Market Share by Application (2025-2030)
 Table 64. Global Icatibant Acetate Injection Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Icatibant Acetate Injection Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Icatibant Acetate Injection Revenue Market Share by Application (2019-2024)
 Table 67. Global Icatibant Acetate Injection Revenue Market Share by Application (2025-2030)
 Table 68. Global Icatibant Acetate Injection Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Icatibant Acetate Injection Price (US$/Unit) by Application (2025-2030)
 Table 70. Takeda Pharmaceuticals Company Information
 Table 71. Takeda Pharmaceuticals Description and Business Overview
 Table 72. Takeda Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Takeda Pharmaceuticals Icatibant Acetate Injection Product
 Table 74. Takeda Pharmaceuticals Recent Developments/Updates
 Table 75. Eugia Pharma Specialities Company Information
 Table 76. Eugia Pharma Specialities Description and Business Overview
 Table 77. Eugia Pharma Specialities Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Eugia Pharma Specialities Icatibant Acetate Injection Product
 Table 79. Eugia Pharma Specialities Recent Developments/Updates
 Table 80. Glenmark Pharmaceuticals Company Information
 Table 81. Glenmark Pharmaceuticals Description and Business Overview
 Table 82. Glenmark Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Glenmark Pharmaceuticals Icatibant Acetate Injection Product
 Table 84. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 85. Sandoz Company Information
 Table 86. Sandoz Description and Business Overview
 Table 87. Sandoz Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Sandoz Icatibant Acetate Injection Product
 Table 89. Sandoz Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Cipla Icatibant Acetate Injection Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. Fresenius Kabi Company Information
 Table 96. Fresenius Kabi Description and Business Overview
 Table 97. Fresenius Kabi Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Fresenius Kabi Icatibant Acetate Injection Product
 Table 99. Fresenius Kabi Recent Developments/Updates
 Table 100. Jiangsu Hengrui Pharmaceuticals Company Information
 Table 101. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
 Table 102. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product
 Table 104. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
 Table 105. Chengdu Shengnuo Biology Pharmacy Company Information
 Table 106. Chengdu Shengnuo Biology Pharmacy Description and Business Overview
 Table 107. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product
 Table 109. Chengdu Shengnuo Biology Pharmacy Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Icatibant Acetate Injection Distributors List
 Table 113. Icatibant Acetate Injection Customers List
 Table 114. Icatibant Acetate Injection Market Trends
 Table 115. Icatibant Acetate Injection Market Drivers
 Table 116. Icatibant Acetate Injection Market Challenges
 Table 117. Icatibant Acetate Injection Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Icatibant Acetate Injection
 Figure 2. Global Icatibant Acetate Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Icatibant Acetate Injection Market Share by Type: 2023 & 2030
 Figure 4. Original Drug Product Picture
 Figure 5. Generic Drug Product Picture
 Figure 6. Global Icatibant Acetate Injection Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Icatibant Acetate Injection Market Share by Application: 2023 & 2030
 Figure 8. Hospital and Clinic
 Figure 9. Pharmacy
 Figure 10. Other
 Figure 11. Global Icatibant Acetate Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Icatibant Acetate Injection Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Icatibant Acetate Injection Sales (2019-2030) & (K Units)
 Figure 14. Global Icatibant Acetate Injection Average Price (US$/Unit) & (2019-2030)
 Figure 15. Icatibant Acetate Injection Report Years Considered
 Figure 16. Icatibant Acetate Injection Sales Share by Manufacturers in 2023
 Figure 17. Global Icatibant Acetate Injection Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Icatibant Acetate Injection Players: Market Share by Revenue in Icatibant Acetate Injection in 2023
 Figure 19. Icatibant Acetate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Icatibant Acetate Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Icatibant Acetate Injection Sales Market Share by Country (2019-2030)
 Figure 22. North America Icatibant Acetate Injection Revenue Market Share by Country (2019-2030)
 Figure 23. United States Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Icatibant Acetate Injection Sales Market Share by Country (2019-2030)
 Figure 26. Europe Icatibant Acetate Injection Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Icatibant Acetate Injection Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Icatibant Acetate Injection Revenue Market Share by Region (2019-2030)
 Figure 34. China Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Icatibant Acetate Injection Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Icatibant Acetate Injection Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Icatibant Acetate Injection Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Icatibant Acetate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Icatibant Acetate Injection by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Icatibant Acetate Injection by Type (2019-2030)
 Figure 53. Global Icatibant Acetate Injection Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Icatibant Acetate Injection by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Icatibant Acetate Injection by Application (2019-2030)
 Figure 56. Global Icatibant Acetate Injection Price (US$/Unit) by Application (2019-2030)
 Figure 57. Icatibant Acetate Injection Value Chain
 Figure 58. Icatibant Acetate Injection Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart